Skip to main content
. 2018 Dec 17;2018(12):CD003877. doi: 10.1002/14651858.CD003877.pub5

Özen 2012.

Methods Parallel design
Funding: not stated
Location: Turkey
Participants Inclusion criteria: ASA 1; children with definitely or slightly negative behaviour ratings on the Frankl Behaviour Rating Scale and who had prior experience with sedation or general anaesthesia
n = 240, 116 girls, 124 boys
Age range = 4 to 6 years
Interventions Group 1 (n = 60): midazolam (0.20 mg/kg) (40 mg/ml) intranasally, inhalation sedation 50%/50% nitrous oxide/oxygen
Group 2 (n = 60): midazolam (0.75 mg/kg) (15 mg/3 ml) orally, inhalation sedation 50%/50% nitrous oxide/oxygen
Group 3 (n = 60): midazolam (0.50 mg/kg) (15 mg/3 ml) orally, inhalation sedation 50%/50% nitrous oxide/oxygen
Group 4 (n = 60): inhalation sedation 50%/50% nitrous oxide/oxygen
Outcomes Bispectral Index System; modified scale to classify behaviour; Vancouver Recovery Scale
Notes Restraint used
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding ‐ Participant Unclear risk Not described
Blinding ‐ Operator/sedationist Unclear risk Not described
Blinding ‐ Outcome assessor Unclear risk Not described
Incomplete outcome assessment High risk Difficult to gather if dropouts had occurred. Percentage of patients that did not accept route of treatment mentioned
Free of selective reporting Low risk All planned outcomes reported
Free of other bias High risk Little information on participants in each group as baseline

ASA I/ASA II = American Society of Anesthesiologists (ASA) physical status classification; BIS = bispectral index; DSTG = Dental SedationTeachers Group scale; ITT = intention‐to‐treat; IV = intravenous; LA = local anaesthesia; min = minute; RCT = randomised controlled trial; SD = standard deviation; SE = standard error.